Find clinical trials for Diabetes in New Haven, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Diabetes trials near New Haven, CT, USA:
The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...
Phase 2
New Haven, Connecticut, United States and 22 other locations
The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...
Phase 4
New Haven, Connecticut, United States and 9 other locations
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Waterbury, Massachusetts, United States of America and 40 other locations
The primary objective of this study is to demonstrate that KAI-9531 subcutaneous (SC) injection once weekly is superior to placebo on:* Percent chang...
Phase 3
Stamford, Connecticut, United States and 6 other locations
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Bridgeport, Connecticut, United States of America and 89 other locations
This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple a...
Phase 1, Phase 2
Syosset, New York, United States and 28 other locations
The purpose of this research study is to test a mindfulness app called Calm Health among young adults with type 1 diabetes or other absolute...
New Haven, Connecticut, United States
control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...
Phase 2
New Haven, Connecticut, United States and 29 other locations
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...
Phase 3
Waterbury, Massachusetts, United States of America and 228 other locations
CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors ...
Phase 2
Smithtown, New York, United States and 41 other locations
Clinical trials
Research sites
Resources
Legal